MK-8141

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8141, covering 2015-10-16 to 2015-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006) [Phase 2]

See pricing